None listed
Conditions
Interventions
Medical Device : non-polymer drug-coated stent : 1,500 people
ultrathin strut biodegradable polymer drug-eluting stent : 1,500 people
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subject must be at least 19 years of age 2) Subject who is able to understand risks, benefits and treatment alternatives and sign informed consent voluntarily. 3) Patients with at least one lesion with equal or greater than 50% diameter stenosis requiring treatment with drug-eluting stents (DES) in native coronary artery or graft
Exclusion criteria
Exclusion criteria: 1) Patients unable to provide consent 2) Patients with known intolerance major components of drug-eluting stents 3) Patients who have non-cardiac co-morbid conditions with life expectancy <1 year or that may result in protocol non-compliance (per site investigator’s medical judgment) 4) Pregnant or lactating women 5) patient with hemodynamic instability or psychogenic shock
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiac death, target vessel-myocardial infarction [MI], or clinically indicated target-lesion revascularization by percutaneous or surgical methods). | — |
Secondary
| Measure | Time frame |
|---|---|
| a composite of cardiac death, target vessel-myocardial infarction, or clinically indicated target-lesion revascularization by percutaneous or surgical methods | — |
Countries
Korea, Republic of
Contacts
Public ContactHyeonJu LEE
Samsung Medical Center
Outcome results
None listed